Industry Trends

Amcor Acquires Bemis: A Cost Controller's Take on the Packaging Consolidation

When I first saw the headlines about Amcor acquiring Bemis back in 2019, I'll admit my initial reaction was pretty simple: "Great, another merger. Probably means less competition and higher prices for us." I'm a procurement manager for a 250-person medical device company, and I've managed our flexible packaging budget—about $180,000 annually—for six years. My job isn't to follow corporate drama; it's to track every invoice in our cost system and ensure we're getting value. So, I didn't care about stock prices or synergy targets. I cared about what it meant for my quotes, my supply chain, and my total cost of ownership (TCO).

Five years later, having watched this consolidation play out from the buyer's seat, I've got a more nuanced view. It's not a simple "good vs. bad" story. It's a classic case of weighing potential upside against tangible risk. The upside was access to Amcor's global network and R&D. The risk was becoming a smaller fish in a much bigger pond, with all the service and pricing opacity that can bring. I kept asking myself: are the promised innovations worth the potential loss of leverage and attention?

The Framework: How I Evaluate a Supplier Merger

Before we dive into Amcor-Bemis specifically, let me explain how I frame this. I don't compare "before the merger" to "after the merger" as one blob. That's too vague. Instead, I break it down into the dimensions that actually impact my P&L and my stress levels:

• Pricing & Transparency: Is the quoted price the real price? Do hidden fees pop up?
• Innovation & Product Range: Do I get access to better barrier films or healthcare packaging solutions?
• Service & Reliability: Does my account get the same attention? Are lead times consistent?
• Strategic Risk: Am I putting too many eggs in one basket?

Let's run the Amcor-Bemis deal through this grid.

Dimension 1: Pricing & Transparency – The Hidden Cost of Scale

Amcor (Post-Acquisition) vs. The Pre-Merger Bemis

Initial Quote vs. Final Cost: My experience with the pre-merger Bemis was pretty straightforward. Their quotes were detailed, breaking out film costs, conversion, and tooling. With the integrated Amcor, I've noticed a shift toward more bundled, "simplified" pricing. On the surface, that looks cleaner. But here's the catch—when we needed a rush order for a critical clinical trial last year, the expedite fee wasn't in the original master agreement. It was a 40% premium tacked on later. That's a hidden cost. To be fair, most large suppliers do this, but the pre-merger Bemis team was usually clearer about potential premium scenarios upfront.

Negotiation Leverage: This is the big one. When I was spending $180k with Bemis, I was a decent-sized account. Now, that same spend is a rounding error in Amcor's $15+ billion revenue stream. My leverage to negotiate on price or payment terms has objectively decreased. The numbers said consolidation might bring economies of scale that could be passed on. My gut said my little account wouldn't see them. Turns out, my gut was mostly right. Our per-unit costs have remained flat, while our ability to push back on annual increases has weakened.

Verdict: A slight loss for buyers on transparency and leverage. You're trading a potentially more predictable, relationship-driven pricing model for a more corporate, less flexible one. The "simplified" price might hide more than it reveals.

Dimension 2: Innovation & Product Range – Where the Deal Actually Delivers

The Combined Portfolio vs. Going It Alone

Healthcare Packaging Expertise: This is where the acquisition logic makes the most sense from my desk. Bemis had deep know-how in medical device packaging and sterile barrier films. Amcor brought massive R&D resources and global material science capabilities. For a project last quarter, we needed a high-barrier film for a new implantable device. The combined Amcor team could pull from a broader library of materials—including some proprietary Amcor blends—that the old Bemis might not have had ready access to. We got a better-performing spec, which probably saved us a qualification cycle.

One-Stop-Shop Potential: Previously, if we needed a specialty pouch and a rigid tray, we'd go to two vendors. Now, in theory, Amcor can handle both. That's a genuine TCO win if it reduces administrative overhead, simplifies quality audits, and consolidates shipments. I say "in theory" because making it work seamlessly on the service side is harder than combining product catalogs.

Verdict: A clear win on paper and a potential win in practice. The expanded technical portfolio and R&D firepower are real advantages, especially for complex healthcare applications. This is the primary upside a cost controller should try to capture post-merger.

Dimension 3: Service & Reliability – The Human Element Fades

Account Management & Communication

This is where I've felt the biggest shift, and it's not unique to Amcor—it's the merger playbook. Our longtime Bemis sales rep and applications engineer, who knew our line speeds and quality quirks, were gone within 18 months. Replaced by a new Amcor account manager covering three times the territory. I said, "We need this film batch traceable due to MDR regulations." They heard, "Send the standard COA." Result: a paperwork scramble that almost delayed a launch.

Lead Time Consistency: Analyzing $180,000 in spending across six years, I found that 15% of our "production delays" were actually supplier-led timeline pushes. Post-merger, during the integration period, that spiked to nearly 30% as systems were combined and orders got lost in the shuffle. It's stabilized now, but it was a costly hidden tax on our operations.

Verdict: A net negative, at least through the transition. Institutional knowledge is lost, and personal relationships that solve problems get deprioritized. You're dealing with a bigger, more bureaucratic machine.

Dimension 4: Strategic Risk – Don't Put All Your Eggs in the Amcor Basket

This is the counterintuitive lesson. You'd think having a giant, financially stable supplier like Amcor is lower risk. And from a "will they go bankrupt?" perspective, it is. But from a procurement risk perspective, it creates a new vulnerability. If 80% of your packaging is now with one behemoth, what happens when they have a plant fire? Or decide to discontinue a film line you've qualified? Your alternative sources have dried up because the industry is more consolidated.

After tracking 200+ orders, I've learned that single-source dependency is a massive hidden cost waiting to happen. Our procurement policy now requires quotes from a minimum of three vendors for any category, because of the reduced competition in markets like flexible packaging post-consolidation.

The Cost Controller's Recommendation: It Depends on Your Profile

So, is the Amcor-Bemis deal good or bad for buyers? Personally, I'd argue there's no universal answer. Here's my scene-by-scene breakdown:

Choose to consolidate your spend with Amcor if:

• You're in healthcare or medical devices and need advanced barrier solutions. The combined R&D is worth the hassle.
• You're a large, global buyer (think $5M+ in packaging). You'll have the clout to get good pricing and attention within the Amcor system.
• You value one-stop-shop convenience for complex packaging needs and have the internal staff to manage the relationship actively.

Maintain alternatives and limit Amcor share if:

• You're a mid-sized or smaller buyer (like me). You risk becoming invisible. Split your business to maintain leverage.
• Your products use fairly standard films. You won't gain much from the fancy innovation, but you'll pay for the corporate overhead.
• Supply chain resilience is your top priority. Diversify your supplier base to mitigate the risk of dependency on a single giant.

The bottom line? Don't get swept up in the "global leader" narrative. Run your own TCO analysis. The vendor who lists all potential fees upfront—even if the total looks higher—usually costs less in the end than the one with a "simple" price and a history of post-merger integration headaches. I've learned to ask "what's NOT included" long before I ask "what's the price." That's the real lesson any acquisition teaches a cost controller.